Plegridy Injection, Solution
Product Images NDC 64406-017

86 FDA label images from Biogen Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 86 technical images submitted to the FDA as part of the official labeling for Plegridy (NDC 64406-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Ple00 0028 01)

Figure (Ple00 0028 01)
A line graph showing the percentage of patients with relapses over 48 weeks comparing Plegridy (peginterferon beta-1a) 125 mcg every 14 days to placebo. The graph indicates a lower relapse percentage for Plegridy (18.7%) compared to placebo (29.1%). The x-axis represents time on study in weeks, and the y-axis shows the percentage of patients with relapses.*
FDA Label Image

Figure A (Ple00 0028 02)

Figure A (Ple00 0028 02)
Illustration of two Plegridy Pens for subcutaneous injection, showing a 63 mcg orange pen and a 94 mcg blue pen, used for dosing peginterferon beta-1a. The pens are color-coded and labeled with their respective microgram strengths.*
FDA Label Image

Figure B (Ple00 0028 03)

Figure B (Ple00 0028 03)
An instructional illustration showing four medical supplies: an alcohol wipe, a gauze pad, an adhesive bandage, and a sharps container. Each item is labeled and visually represented with simple icons. This is likely part of a usage or disposal guide for a medication kit.*
FDA Label Image

Figure C (Ple00 0028 04)

Figure C (Ple00 0028 04)
An instructional illustration labeled Figure C depicting the Plegridy Pen, a subcutaneous injection device used to deliver peginterferon beta-1a. The image shows the pen's side profile with detailed design elements such as a window and cap, emphasizing the device's shape and key features for use.*
FDA Label Image

Figure D (Ple00 0028 05)

Figure D (Ple00 0028 05)
An illustration showing the Plegridy Pen, a prefilled auto-injector pen for subcutaneous injection of peginterferon beta-1a. The pen is white with blue accents and features a viewing window and a cap, depicting its design as part of the injection process.*
FDA Label Image

Figure E (Ple00 0028 06)

Figure E (Ple00 0028 06)
An instructional diagram of the Plegridy Pen showing labeled parts including the Green Stripes Visible, Injection Status Window, Body, Medicine Window, Medicine Visible, and Cap. This illustration helps identify key components of the peginterferon beta-1a subcutaneous injection device.*
FDA Label Image

Figure F (Ple00 0028 07)

Figure F (Ple00 0028 07)
Illustration of the Plegridy Pen kit, a subcutaneous injection device for peginterferon beta-1a 125 mcg/0.5 mL. The diagram highlights three features: the Injection Status Window at the top indicating dose status, the Expiration Date label on the side of the pen, and the Medicine Window showing the medication inside the device.*
FDA Label Image

Figure G (Ple00 0028 08)

Figure G (Ple00 0028 08)
Illustration showing recommended subcutaneous injection sites for Plegridy Pen (peginterferon beta-1a) 125 mcg/0.5 mL kit. Highlighted areas include the abdomen around the navel and the front thighs, as well as the outer upper arm.*
FDA Label Image

Figure I (Ple00 0028 09)

Figure I (Ple00 0028 09)
An instructional illustration showing a hand holding the Plegridy Pen at a 90-degree angle to the skin, preparing to administer a subcutaneous injection. The figure includes a close-up inset demonstrating correct pen positioning over the injection site on the thigh.*
FDA Label Image

Figure J (Ple00 0028 10)

Figure J (Ple00 0028 10)
An instructional illustration showing a hand holding a Plegridy Pen injection device, positioned for subcutaneous injection with an arrow pointing downward. A caption 'Clicking Starts' is highlighted above the pen, indicating the activation of the device upon injection.*
FDA Label Image

Figure K (Ple00 0028 11)

Figure K (Ple00 0028 11)
An instructional illustration showing a hand holding the Plegridy Pen in a vertical position for subcutaneous injection. It includes a smaller inset indicating the pen clicks during use and clicking stops when the injection is complete.*
FDA Label Image

Figure L (Ple00 0028 12)

Figure L (Ple00 0028 12)
An instructional illustration showing a hand holding the Plegridy Pen at a 90-degree angle against the thigh for subcutaneous injection. An upward-pointing arrow indicates the motion of pulling or lifting the pen away from the injection site after administration.*
FDA Label Image

Figure M (Ple00 0028 13)

Figure M (Ple00 0028 13)
An instructional illustration of the Plegridy Pen, showing three labeled features: an Injection Status Window near the top, a Medicine Window below it, and a Yellow Plunger at the bottom, designed for subcutaneous injection of peginterferon beta-1a.*
FDA Label Image

Figure N (Ple00 0028 14)

Figure N (Ple00 0028 14)
Illustration of the Plegridy Pen injection device showing labeled parts including the green checkmark visible, medicine window, needle cover with needle inside, injection status window, body, and yellow plunger visible sections.*
FDA Label Image

Figure A (Ple00 0028 15)

Figure A (Ple00 0028 15)
An instructional diagram of the Plegridy Pen showing parts labeled as Green Stripes Visible, Injection Status Window, Medicine Window, Body, Medicine Visible, and Cap, illustrating key features of the subcutaneous injection device.*
FDA Label Image

Figure B (Ple00 0028 16)

Figure B (Ple00 0028 16)
Illustration showing four medical items labeled as Alcohol Wipe, Gauze Pad, Adhesive Bandage, and Sharps Container. Each item is depicted with a simple black-and-white line drawing, except the Sharps Container which is orange with a gray lid, indicating components used for subcutaneous injection care.*
FDA Label Image

Figure C (Ple00 0028 17)

Figure C (Ple00 0028 17)
An instructional illustration of the Plegridy Pen, a subcutaneous injection device for peginterferon beta-1a 125 ug/.5mL. The image highlights three key features: the Injection Status Window, the Expiration Date, and the Medicine Window, which are labeled to show their locations on the pen for user reference.*
FDA Label Image

Figure D (Ple00 0028 18)

Figure D (Ple00 0028 18)
An instructional illustration showing appropriate subcutaneous injection sites for the Plegridy Pen. The diagram highlights the abdomen, front thighs, and back upper arms as recommended areas for injection on a human figure. The injection sites are shaded in blue on both front and side views.*
FDA Label Image

Figure E (Ple00 0028 19)

Figure E (Ple00 0028 19)
An illustration showing the step of removing or attaching the cap from the Plegridy Pen, a subcutaneous injection kit containing peginterferon beta-1a 125 mcg/0.5 mL by Biogen Inc. The image depicts a hand holding the pen and another hand pulling the cap upward or downward with guide arrows.*
FDA Label Image

Figure F (Ple00 0028 20)

Figure F (Ple00 0028 20)
An instructional illustration showing a person holding the Plegridy Pen at a 90-degree angle to the skin on their thigh, indicating proper injection technique for subcutaneous administration of the peginterferon beta-1a pen.*
FDA Label Image

Figure G (Ple00 0028 21)

Figure G (Ple00 0028 21)
An instructional illustration showing a hand holding the Plegridy Pen vertically and pressing it down onto the skin to activate the injection, indicated by a 'Clicking Starts' label and a downward arrow.*
FDA Label Image

Figure H (Ple00 0028 22)

Figure H (Ple00 0028 22)
An instructional illustration showing a hand holding a Plegridy Pen and pressing it against the skin for subcutaneous injection. The top inset depicts the pen clicking when pressed correctly, indicating the start and stop of the injection process.*
FDA Label Image

Figure I (Ple00 0028 23)

Figure I (Ple00 0028 23)
An instructional illustration showing a person holding a Plegridy Pen, positioned to inject the medication subcutaneously into the thigh. The image includes an upward-pointing arrow, indicating the direction to remove or withdraw the pen after injection.*
FDA Label Image

Figure J (Ple00 0028 24)

Figure J (Ple00 0028 24)
An instructional diagram of the Plegridy Pen showing three labeled features: the Injection Status Window near the top, the Medicine Window in the middle with visible liquid, and the Yellow Plunger at the bottom, illustrating the parts relevant for subcutaneous injection with the peginterferon beta-1a pen device.*
FDA Label Image

Figure K (Ple00 0028 25)

Figure K (Ple00 0028 25)
An instructional diagram of the Plegridy Pen subcutaneous injection device showing labeled parts including the green checkmark visible, medicine window, needle cover, needle inside, injection status window, body, and yellow plunger visible, illustrating the components and indicators of the pen for administration.*
FDA Label Image

Figure A (Ple00 0028 26)

Figure A (Ple00 0028 26)
Illustration showing two prefilled syringes labeled with dosages and color coding: a 63 mcg prefilled syringe marked as the Orange Syringe and a 94 mcg prefilled syringe marked as the Blue Syringe. The syringes are part of a dosing kit for plegridy pen administration.*
FDA Label Image

Figure B (Ple00 0028 27)

Figure B (Ple00 0028 27)
Illustration showing four labeled components: an alcohol wipe, gauze pads, an adhesive bandage, and a sharps container, typically used for subcutaneous injection procedures.*
FDA Label Image

Figure C (Ple00 0028 28)

Figure C (Ple00 0028 28)
The image shows a Plegridy Pen prefilled syringe containing peginterferon beta-1a injection, 125 micrograms per 0.5 mL. The syringe has clear measurement markings and an orange cap on the needle end. It is labeled as a subcutaneous injection for prescription use, manufactured by Biogen Inc.*
FDA Label Image

Figure D (Ple00 0028 29)

Figure D (Ple00 0028 29)
Plegridy Pen containing peginterferon beta-1a 125 micrograms per 0.5 mL in a prefilled, subcutaneous injection syringe. The image shows a single dose syringe with a clear barrel and a black plunger. The syringe label includes the strength and dosing information. Manufactured by Biogen Inc.*
FDA Label Image

Figure E (Ple00 0028 30)

Figure E (Ple00 0028 30)
The image shows a Plegridy Pen prefilled syringe with peginterferon beta-1a 125 mcg/0.5 mL. The syringe parts labeled include the needle cover, medicine inside the syringe body, and the plunger at the opposite end. It is a subcutaneous delivery kit supplied by Biogen Inc.*
FDA Label Image

Figure F And G (Ple00 0028 31)

Figure F And G (Ple00 0028 31)
An instructional diagram showing a prefilled syringe labeled with lot number, expiration date, and medicine area. Two magnified insets highlight the locations of the expiration date and medicine on the syringe label.*
FDA Label Image

Figure H (Ple00 0028 32)

Figure H (Ple00 0028 32)
Instructional illustration showing preferred injection sites for Plegridy Pen subcutaneous injection. The highlighted areas include the front thigh, abdomen, and back of the upper arms as recommended injection locations for peginterferon beta-1a 125 mcg/0.5 mL.*
FDA Label Image

Figure I (Ple00 0028 33)

Figure I (Ple00 0028 33)
An instructional diagram labeled Figure I showing a step-by-step process focusing on handling a pen needle. The top part illustrates removing the needle cover by pulling upward, and the bottom part depicts pushing the needle cover downward onto the needle. This likely demonstrates proper needle preparation or disposal for the Plegridy Pen subcutaneous injection.*
FDA Label Image

Figure J (Ple00 0028 34)

Figure J (Ple00 0028 34)
Illustration showing a hand pinching the skin, likely depicting a technique for subcutaneous injection. This image is associated with the Plegridy Pen, a kit for delivering peginterferon beta-1a subcutaneously in a 125 ug/.5mL strength, labeled by Biogen Inc.*
FDA Label Image

Figure K (Ple00 0028 35)

Figure K (Ple00 0028 35)
Instructional illustration showing how to properly hold and position the Plegridy Pen at a 90-degree angle to the skin for subcutaneous injection. The image depicts a hand holding the pen syringe and an arrow indicating the correct injection angle on the skin.*
FDA Label Image

Figure L (Ple00 0028 36)

Figure L (Ple00 0028 36)
An instructional illustration showing a hand holding and pressing down a syringe to administer a subcutaneous injection. The needle is inserted into the skin at the injection site, with an arrow indicating the downward pressing motion.*
FDA Label Image

Figure M (Ple00 0028 37)

Figure M (Ple00 0028 37)
An illustration showing a hand holding a prefilled syringe positioned above an arm, with a green arrow indicating the direction for subcutaneous injection. The syringe contains a clear liquid with a visible plunger and needle tip, demonstrating the injection process technique for a subcutaneous medication.*
FDA Label Image

Figure A (Ple00 0028 38)

Figure A (Ple00 0028 38)
Plegridy Pen containing peginterferon beta-1a 125 mcg/0.5 mL is shown as a prefilled syringe kit for subcutaneous administration. The image labels the syringe components: needle cover, medicine in the syringe body, and the plunger, illustrating the drug's delivery device. Manufactured by Biogen Inc.*
FDA Label Image

Figure B (Ple00 0028 39)

Figure B (Ple00 0028 39)
Illustration showing components included in the Plegridy Pen kit by Biogen Inc. The image depicts an alcohol wipe, gauze pad, adhesive bandage, and a sharps container, which are used for subcutaneous injection procedures with the peginterferon beta-1a prefilled pen.*
FDA Label Image

Figures C And D (Ple00 0028 40)

Figures C And D (Ple00 0028 40)
Illustration showing a syringe labeled with lot number and expiration date. Two zoomed-in views highlight the locations of the expiration date and the medicine within the syringe.*
FDA Label Image

Figure E (Ple00 0028 41)

Figure E (Ple00 0028 41)
An instructional illustration showing recommended injection sites for the Plegridy Pen (peginterferon beta-1a) subcutaneous injection. It highlights areas on the thighs, abdomen, and back of the upper arms where injections can be administered.*
FDA Label Image

Figure F (Ple00 0028 42)

Figure F (Ple00 0028 42)
An instructional illustration showing the removal of a needle cover from a syringe, with a green arrow indicating upward removal of the needle cover to expose the needle. The syringe is being held by a hand, demonstrating part of an injection preparation process.*
FDA Label Image

Figure G (Ple00 0028 43)

Figure G (Ple00 0028 43)
An instructional illustration showing a hand administering a subcutaneous injection on the forearm. This figure likely demonstrates the proper technique for self-injection using the Plegridy Pen, peginterferon beta-1a, 125 mcg/0.5 mL KIT by Biogen Inc.*
FDA Label Image

Figure H (Ple00 0028 44)

Figure H (Ple00 0028 44)
An instructional illustration showing a hand holding a prefilled syringe at a 90-degree angle to the skin surface for subcutaneous injection. A downward arrow indicates the direction of needle insertion. This image is associated with the Plegridy Pen kit for peginterferon beta-1a administration.*
FDA Label Image

Figure I (Ple00 0028 45)

Figure I (Ple00 0028 45)
An instructional illustration showing a hand holding a prefilled syringe for subcutaneous injection, with the needle inserted into the skin of the arm. The image demonstrates proper injection technique likely related to the Plegridy Pen kit containing peginterferon beta-1a 125 mcg/0.5 mL.*
FDA Label Image

Figure J (Ple00 0028 46)

Figure J (Ple00 0028 46)
An instructional illustration showing a hand holding a syringe with a needle poised above a skin surface, accompanied by a green upward arrow indicating the direction of injection. This image demonstrates the proper technique for subcutaneous injection using the Plegridy Pen (peginterferon beta-1a) 125 mcg/0.5 mL kit by Biogen Inc.*
FDA Label Image

Figure (Ple00 0028 47)

Figure (Ple00 0028 47)
The image shows parts of the Plegridy Pen kit for subcutaneous injection, including a 23 gauge, 1¼ inch long sterile needle and a Plegridy prefilled syringe. The syringe is for peginterferon beta-1a, dosage strength 125 mcg/0.5 mL, manufactured by Biogen Inc.*
FDA Label Image

Figure (Ple00 0028 48)

Figure (Ple00 0028 48)
Illustration showing four components included in the Plegridy Pen kit: an alcohol wipe, gauze pad, adhesive bandage, and a sharps container for safe disposal of used needles.*
FDA Label Image

Figure A (Ple00 0028 49)

Figure A (Ple00 0028 49)
An instructional diagram of a syringe illustrating labeled parts including the plunger, syringe barrel, cap, and protective rubber cover. The image is likely part of a usage guide for the Plegridy Pen kit, which contains peginterferon beta-1a for subcutaneous use.*
FDA Label Image

Figure B (Ple00 0028 50)

Figure B (Ple00 0028 50)
An instructional illustration showing a human hand holding the Plegridy Pen device, a subcutaneous injection pen for peginterferon beta-1a 125 micrograms/0.5 mL. The image demonstrates the proper grip and handling technique for self-administration using this prescription drug kit by Biogen Inc.*
FDA Label Image

Figure C (Ple00 0028 51)

Figure C (Ple00 0028 51)
Illustration showing a person holding a Plegridy Pen pre-filled syringe by Biogen Inc. The image highlights the subcutaneous injection step, with fingers positioned on the syringe and a red safety clip near the needle end, demonstrating proper handling or injection technique for the peginterferon beta-1a 125 mcg/0.5 mL kit.*
FDA Label Image

Figure D (Ple00 0028 52)

Figure D (Ple00 0028 52)
An instructional diagram showing the removal of a protective cap from the glass syringe tip of a Plegridy Pen. The diagram features a red curved arrow indicating the direction to pull the cap off the syringe tip, which is designed for subcutaneous injection.*
FDA Label Image

Figure E (Ple00 0028 53)

Figure E (Ple00 0028 53)
An instructional illustration showing a hand holding a Plegridy Pen to administer peginterferon beta-1a. The image depicts the removal of a protective cap from the pen, guided by a red arrow pointing downward, indicating preparation for subcutaneous injection.*
FDA Label Image

Figure F (Ple00 0028 54)

Figure F (Ple00 0028 54)
An instructional illustration showing hands using a Plegridy Pen for subcutaneous injection. The image demonstrates the proper technique of holding the pen and rotating its components as part of the injection process.*
FDA Label Image

Figure G (Ple00 0028 55)

Figure G (Ple00 0028 55)
An illustration showing two views of a lower leg and foot, one from the front and one from the side. Both views have a red square marked on the upper front thigh area, indicating a site for subcutaneous injection, consistent with instructions for Plegridy Pen (peginterferon beta-1a) use.*
FDA Label Image

Figure H (Ple00 0028 56)

Figure H (Ple00 0028 56)
An instructional illustration showing hands assembling the Plegridy Pen by connecting the pen device components. A red arrow indicates the direction to attach or insert parts for preparation before use.*
FDA Label Image

Figure I (Ple00 0028 57)

Figure I (Ple00 0028 57)
An instructional illustration showing a hand holding a Plegridy Pen pre-filled syringe above a person's skin at a 90-degree angle, with a red arrow indicating the injection direction for subcutaneous administration.*
FDA Label Image

Figure J (Ple00 0028 58)

Figure J (Ple00 0028 58)
Instructional illustration showing proper use of the Plegridy Pen, a subcutaneous injection kit of peginterferon beta-1a 125 mcg/0.5 mL. The image demonstrates a hand pressing the plunger of the pen into the skin of the upper arm, indicating the injection process.*
FDA Label Image

Figure K (Ple00 0028 59)

Figure K (Ple00 0028 59)
An instructional illustration showing a hand holding a needle at a 90-degree angle to a person's skin, with an upward arrow indicating the direction for inserting or withdrawing the needle for a subcutaneous injection, related to Plegridy Pen usage.*
FDA Label Image

Figure (Ple00 0028 60)

Figure (Ple00 0028 60)
An instructional illustration showing parts of the Plegridy Pen, including a yellow clip labeled '1/2' and a purple clip labeled '3/4', a 23 gauge, 1¼ inch long sterile needle, and a Plegridy prefilled syringe. The image highlights components used for subcutaneous administration of peginterferon beta-1a.*
FDA Label Image

Figure (Ple00 0028 61)

Figure (Ple00 0028 61)
An illustrated diagram displaying four items commonly found in a medication administration kit: an alcohol wipe, a gauze pad, an adhesive bandage, and a sharps container. Each item is labeled above its corresponding image.*
FDA Label Image

Figure A (Ple00 0028 62)

Figure A (Ple00 0028 62)
An illustration labeled "Figure A" showing a Plegridy Pen syringe kit component for subcutaneous injection. The syringe is annotated with labeled parts including the plunger, syringe barrel, protective rubber cover, and cap. The image visually explains the parts of the injection device.*
FDA Label Image

Figure B (Ple00 0028 63)

Figure B (Ple00 0028 63)
Illustration showing a human hand holding a Plegridy Pen, a subcutaneous injection device for peginterferon beta-1a 125 mcg/.5 mL. The image visually demonstrates the correct grip positioning for administering the injection with the pen.*
FDA Label Image

Figure C (Ple00 0028 64)

Figure C (Ple00 0028 64)
An instructional illustration showing hands holding a Plegridy Pen, a subcutaneous injection device for peginterferon beta-1a 125 mcg/.5 mL. The image demonstrates the proper technique for preparing or administering the injection using the pen device.*
FDA Label Image

Figure D (Ple00 0028 65)

Figure D (Ple00 0028 65)
An instructional diagram showing the removal of a glass syringe tip from a container cap, indicated by a red curved arrow and labeled 'glass syringe tip.' This figure appears to be part of usage instructions for the Plegridy Pen kit.*
FDA Label Image

Figure E (Ple00 0028 66)

Figure E (Ple00 0028 66)
An instructional illustration showing a hand holding a vial and another hand drawing liquid into a syringe. A red arrow indicates the downward direction for inserting the needle into the vial for injection preparation. This is likely part of instructions for using the Plegridy Pen kit containing peginterferon beta-1a.*
FDA Label Image

Figure F (Ple00 0028 67)

Figure F (Ple00 0028 67)
An instructional illustration showing hands preparing the Plegridy Pen kit for subcutaneous injection. The image depicts one hand holding a syringe and the other adjusting a part of the pen or syringe, demonstrating the setup procedure for administering peginterferon beta-1a 125 mcg/0.5 mL.*
FDA Label Image

Figure G (Ple00 0028 68)

Figure G (Ple00 0028 68)
An instructional image from Plegridy Pen kit illustrates two doses of peginterferon beta-1a for subcutaneous injection. It shows a yellow device labeled '1/2 Dose' for Dose 1 and a purple device labeled '3/4 Dose' for Dose 2, each secured in a white tray with corresponding dose instructions above.*
FDA Label Image

Figure H (Ple00 0028 69)

Figure H (Ple00 0028 69)
An instructional diagram labeled 'Figure H' showing the collar component of a pen injector device. The image highlights the collar section of the pen, likely part of a step-by-step guide for using the Plegridy Pen, peginterferon beta-1a kit for subcutaneous injection.*
FDA Label Image

Figure I (Ple00 0028 70)

Figure I (Ple00 0028 70)
An instructional illustration labeled Figure I showing a syringe with a yellow safety guard positioned alongside it. The syringe is marked to indicate a measurement of 1/2, likely representing volume or dose measurement. This figure appears to be part of usage or administration instructions for the Plegridy Pen kit.*
FDA Label Image

Figure J (Ple00 0028 71)

Figure J (Ple00 0028 71)
An instructional illustration showing a purple Plegridy Pen pre-filled syringe with the dosage strength marked as 3/4, part of the administration kit for subcutaneous injection of peginterferon beta-1a 125 mcg/0.5 mL, manufactured by Biogen Inc.*
FDA Label Image

Figure K (Ple00 0028 72)

Figure K (Ple00 0028 72)
An instructional diagram labeled as Figure K showing a yellow device part with a tab labeled 'Door.' This illustration is likely part of the Plegridy Pen kit instructions for use.*
FDA Label Image

Figure L (Ple00 0028 73)

Figure L (Ple00 0028 73)
An instructional diagram showing a Plegridy Pen autoinjector positioned above a yellow holder or stabilizer, with red arrows indicating how the pen fits or is inserted into the holder. The image appears to guide on the correct placement of the autoinjector device for use or storage.*
FDA Label Image

Figure M (Ple00 0028 74)

Figure M (Ple00 0028 74)
An illustration of a Plegridy Pen injection device showing its internal syringe mechanism, highlighting components indicated by red arrows. The device is designed for subcutaneous administration of peginterferon beta-1a at a strength of 125 micrograms per 0.5 mL as part of a medication kit by Biogen Inc.*
FDA Label Image

Figure N (Ple00 0028 75)

Figure N (Ple00 0028 75)
Illustration showing hands demonstrating the use of the Plegridy Pen, a prefilled injection pen for subcutaneous administration of peginterferon beta-1a. The diagram highlights the step of removing the cap from the needle before injection.*
FDA Label Image

Figure O (Ple00 0028 76)

Figure O (Ple00 0028 76)
An illustration showing a Plegridy Pen injection device for subcutaneous administration. The device is primarily yellow with transparent sections revealing internal components. It includes a needle at the tip and a plunger at the opposite end, designed for delivering 125 micrograms of peginterferon beta-1a as a single dose from the prefilled pen kit.*
FDA Label Image

Figure P (Ple00 0028 77)

Figure P (Ple00 0028 77)
Illustration showing front and side views of a human leg with a red square marking the upper thigh area, indicating the injection site for subcutaneous administration of Plegridy Pen (peginterferon beta-1a 125 mcg/0.5 mL kit).*
FDA Label Image

Figure Q (Ple00 0028 78)

Figure Q (Ple00 0028 78)
An instructional illustration showing a hand holding a Plegridy Pen prefilled syringe and another hand removing the needle cap, indicated by a red arrow pointing away from the pen. The yellow pen contains the medication peginterferon beta-1a 125 mcg/0.5 mL for subcutaneous injection.*
FDA Label Image

Figure R (Ple00 0028 79)

Figure R (Ple00 0028 79)
An instructional illustration showing a hand holding a Plegridy Pen subcutaneous injection device, aligned to inject into the forearm of another person. A downward red arrow indicates the direction of pressing the pen for injection activation.*
FDA Label Image

Figure S (Ple00 0028 80)

Figure S (Ple00 0028 80)
An instructional illustration showing a hand holding a Plegridy Pen, a prefilled subcutaneous injection device containing peginterferon beta-1a. The image demonstrates how to position and use the pen for injection, highlighting the device's design for easy grip and activation.*
FDA Label Image

Figure T (Ple00 0028 81)

Figure T (Ple00 0028 81)
Instructional illustration showing a hand holding a Plegridy Pen prefilled injection device with peginterferon beta-1a 125 mcg/0.5 mL kit, demonstrating subcutaneous injection technique on the arm by pushing the device downward.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
Label for Plegridy Pen injection kit containing peginterferon beta-1a in single doses of 63 mcg/0.5 mL and 94 mcg/0.5 mL for subcutaneous use only. The starter pack includes one prefilled autoinjector of each dose. Labeler is Biogen Inc. The label also features the Biogen logo and states prescription use only.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
Plegridy Pen 125 mcg/0.5 mL injection kit containing 2 single-dose prefilled autoinjectors for subcutaneous use. The label includes the proprietary name Plegridy Pen, generic name peginterferon beta-1a, dosage strength, administration route, and states dispense with enclosed medication guide. Labeler is Biogen Inc.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
Label of Plegridy Pen kit containing peginterferon beta-1a injection. It shows two single-dose syringes with strengths 63 mcg/0.5 mL and 94 mcg/0.5 mL for subcutaneous use. The starter pack is labeled for prescription use only by Biogen Inc.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
Plegridy Pen (peginterferon beta-1a) Injection 125 mcg/0.5 mL subcutaneous kit. Package contains 2 single-dose prefilled syringes. Label shows use every 14 days and indicates Rx only. Manufactured by Biogen Inc.*
FDA Label Image

Principal Display Panel –carton Label (Ple00 0028 86)

Principal Display Panel –carton Label (Ple00 0028 86)
Plegridy Pen (peginterferon beta-1a) Injection kit containing 125 mcg/0.5 mL for intramuscular use only. The package includes 2 single-dose prefilled syringes and 2 needles for intramuscular injection, labeled for use every 14 days. Manufactured by Biogen Inc., with a new route of administration indicated on the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.